{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:07:01Z","timestamp":1791180421305,"version":"4.1.0"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:p>This Viewpoint examines a recent report that used data from the 2022 National Survey on Drug Use and Health to estimate the opioid cascade of care, a framework to characterize the adult US populations who needed and received opioid use disorder (OUD) treatment, as well as discusses ways in which clinicians can close gaps in care.<\/jats:p>","DOI":"10.1001\/jama.2024.11977","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T17:43:21Z","timestamp":1719510201000},"page":"701","source":"Crossref","is-referenced-by-count":24,"title":["Major Gaps in the Cascade of Care for Opioid Use Disorder"],"prefix":"10.1001","volume":"332","author":[{"given":"M. Allison","family":"Arwady","sequence":"first","affiliation":[{"name":"National Center for Injury Prevention and Control, US Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Delphin-Rittmon","sequence":"additional","affiliation":[{"name":"Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"jvp240077r2","doi-asserted-by":"publisher","author":"Dowell","journal-title":"MMWR","DOI":"10.15585\/mmwr.mm7325a1"},{"issue":"9","key":"jvp240077r3","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis.","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"jvp240077r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022.","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"jvp240077r5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/COH.0000000000000212","article-title":"Constructing the cascade of HIV care: methods for measurement.","volume":"11","author":"Haber","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"8","key":"jvp240077r8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/jama.2020.8969","article-title":"Therapies offered at residential addiction treatment programs in the United States.","volume":"324","author":"Beetham","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"jvp240077r9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamapsychiatry.2022.2284","article-title":"Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic.","volume":"79","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"jvp240077r6","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2022 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2023"},{"key":"jvp240077r1","unstructured":"Centers for Disease Control and Prevention. Wide-ranging Online Data for Epidemiologic Research (WONDER). Accessed May 15, 2024. https:\/\/wonder.cdc.gov"},{"key":"jvp240077r7","unstructured":"Centers for Disease Control and Prevention. HV surveillance supplemental report: estimated HIV incidence and prevalence in the United States, 2018\u20132022. May 21, 2024. Accessed May 21, 2024. https:\/\/stacks.cdc.gov\/view\/cdc\/156513"},{"key":"jvp240077r10","unstructured":"Providers Clinical Support System\u2014Medications for Opioid Use Disorders. Accessed May 15, 2024. https:\/\/pcssnow.org\/medications-for-opioid-use-disorder"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2820545\/jama_arwady_2024_vp_240077_1724442749.87026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:08:11Z","timestamp":1725376091000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2820545"}},"subtitle":["Implications for Clinical Practice"],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.11977","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,3]]}}}